Encoded Therapeutics
Latest round
- Series F
Last raised
- Sep 2026
Total raised
- $538M
Investors
- 18
About Encoded Therapeutics
Encoded Therapeutics, Inc.Encoded Therapeutics was founded in 2014 and is headquartered in South San Francisco, US. The company specializes in creating gene therapies for CNS disorders. The founders, Kartik Ramamoorthi and Stephanie Tagliatela, have backgrounds in biotechnology and pharmaceuticals. In September 2026, Encoded Therapeutics, Inc. Encoded Therapeutics specializes in developing genetic medicines aimed at addressing central nervous system (CNS) disorders, which contribute significantly to global morbidity and mortality. The company's core product offerings include novel gene therapies designed to target specific cell types with unique genetic profiles, enhancing specificity, selectivity, and potency compared to earlier therapies. Their flagship product, ETX101, targets Dravet Syndrome, a severe epilepsy form, aiming to provide long-lasting benefits for patients.Encoded Therapeutics generates revenue through partnerships with healthcare institutions and pharmaceutical companies seeking innovative CNS therapies. Their B2B model includes collaborations with research organizations and hospitals for clinical trials and product development, which may involve licensing agreements that provide access to proprietary technologies. While specific pricing structures are not disclosed, the company likely uses value-based pricing models reflecting potential health benefits and cost savings from their advanced gene therapies.
Who invested in Encoded Therapeutics
18 investors across 4 rounds
See all investors in Encoded Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Encoded Therapeutics
Who invested in Encoded Therapeutics?
Encoded Therapeutics has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Encoded Therapeutics raised?
Encoded Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Encoded Therapeutics last raise money?
Encoded Therapeutics's most recent round on record is a Series F, in Sep 2026.
What does Encoded Therapeutics do?
Encoded Therapeutics is a biotechnology company.
Where is Encoded Therapeutics headquartered?
Encoded Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Encoded Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Encoded Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Encoded Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.